Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial.

ABSTRACT:

SUBMITTER: von Tresckow J 

PROVIDER: S-EPMC9343250 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature